Pfizer to supply 100 million more doses of COVID-19 vaccine to U.S. by late July

Pfizer and BioNTech will sell an additional 100 million doses of the COVID-19 vaccine to the United States, doubling the previously agreed upon sale, the pharmaceutical companies and the Trump administration announced Wednesday morning.